Funding
DelphX Launches Non-Brokered Placement of Up to 7 Million Units at C$0.01
By News Desk ·
Key takeaways
- DelphX commenced a non-brokered private placement of up to 7,000,000 units at C$0.01 per unit, for gross proceeds of up to approximately C$70,000.
- Each unit consists of one common share and one warrant exercisable at C$0.06 for two years from issuance.
- DelphX expects to close the offering on or before October 26, 2026, subject to TSX Venture Exchange approval.
DelphX Capital Markets Inc. commenced a non-brokered private placement of up to 7,000,000 units at C$0.01 per unit, for gross proceeds of up to approximately C$70,000. Stock Titan reported the offering on October 19, 2026.
DelphX's Unit Terms and Expected Close
Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at an exercise price of C$0.06 for two years from the date of issuance.
DelphX expects to close the offering on or before October 26, 2026. Completion is subject to the approval of the TSX Venture Exchange. The securities issued will be subject to a hold period of four months plus one day from the date of issuance and, because the units are priced below C$0.05, to the Exchange Hold Period.
DelphX may elect to pay finder's fees to eligible finders under TSX Venture Exchange policies, with details to be announced later. Net proceeds are intended for working capital and corporate overhead, and no more than 10% of gross proceeds will fund investor relations activities.
Aktien reported that DelphX's common shares are quoted in the United States on OTC Markets under the symbol "DPXCF," and that quotation has moved to the Pink Limited market. DelphX does not intend to maintain its OTC quotation, and the DPXCF quote may end in the coming months. The primary listing on the TSX Venture Exchange under the symbol "DELX" is unaffected.
DelphX's Funding Record on akta.pro
According to akta.pro company records, DelphX has 19 funding rounds on record, with a total funding figure of $6.3 million and a last round dated September 2, 2026. The same records list a 2026-09 post ipo equity of $44,051, a 2026-07 post ipo equity of $60,405, a 2026-06 post ipo debt of $28,147 and a 2026-05 post ipo debt of $25,280.
| Date | Type | Amount |
|---|---|---|
| 2026-09 | post ipo equity | $44,051 |
| 2026-07 | post ipo equity | $60,405 |
| 2026-06 | post ipo debt | $28,147 |
| 2026-05 | post ipo debt | $25,280 |
DelphX's Earlier 2026 Placements
On September 22, 2026, DelphX commenced a non-brokered private placement of up to 5.6 million units at C$0.01 each, raising gross proceeds of up to C$56,000, with each unit including a common share and a warrant to buy a share at C$0.06 for two years, Stock Titan reported.
On August 20, 2026, DelphX initiated a non-brokered private placement of up to 5,000,000 units at C$0.01 per unit to raise gross proceeds of up to C$50,000 for working capital and corporate overhead, Newsfile reported.
On August 24, 2026, DelphX clarified the closing of two private placements, one on June 30, 2026 and another on August 5, 2026, each issuing units of one common share and one warrant, Newsfile reported.
DelphX's October 2026 Reporting Change
On October 7, 2026, DelphX said it will adopt semi-annual financial reporting under a CSA pilot program, skipping interim reports for the three and nine months ended September 30, 2026, Stock Titan reported.